Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of UF-021 (isopropyl unoprostone) Eye Drops in Retinitis Pigmentosa
jRCT2080222033Phase 3
- Sponsor
- R-Tech Ueno
- Start
- Feb 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in retinitis pigmentosa (RP) comparing UF-021 eye drops with Placebo eye drops (2 arms).
02
Drugs
unoprostone isopropyl
03
Conditions
retinitis pigmentosa (RP)
Beyond the preview
Go deeper on jRCT2080222033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222033.